Hostname: page-component-cd9895bd7-7cvxr Total loading time: 0 Render date: 2024-12-22T22:32:52.740Z Has data issue: false hasContentIssue false
  • English
  • Français

Surgical Site Infection after Renal Transplantation

Published online by Cambridge University Press:  20 January 2015

Anthony D. Harris ,
Brandon Fleming ,
Jonathan S. Bromberg ,
Peter Rock ,
Grace Nkonge ,
Michele Emerick ,
Michelle Harris-Williams  and
Kerri A. Thom
Anthony D. Harris
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
Brandon Fleming
Affiliation:
University of Maryland School of Pharmacy, Baltimore, Maryland
Jonathan S. Bromberg
Affiliation:
Departments of Surgery and Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, Maryland
Peter Rock
Affiliation:
Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland
Grace Nkonge
Affiliation:
Department of Infection Prevention and Healthcare Epidemiology at the University of Maryland Medical Center, Baltimore, Maryland
Michele Emerick
Affiliation:
Department of Infection Prevention and Healthcare Epidemiology at the University of Maryland Medical Center, Baltimore, Maryland
Michelle Harris-Williams
Affiliation:
Department of Infection Prevention and Healthcare Epidemiology at the University of Maryland Medical Center, Baltimore, Maryland
Kerri A. Thom*
Affiliation:
Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland
*
Address correspondence to Kerri A. Thom, MD, MS, 685 W Baltimore Street, MSTF Suite 334B, Department of Epidemiology and Public Health, University of Maryland School of Medicine, Baltimore, Maryland 21201 ([email protected]).
Get access Rights & Permissions [Opens in a new window]

Abstract

OBJECTIVE

To identify factors associated with the development of surgical site infection (SSI) among adult patients undergoing renal transplantation

DESIGN

A retrospective cohort study

SETTING

An urban tertiary care center in Baltimore, Maryland, with a well-established renal transplantation program that performs ~200–250renal transplant procedures annually

RESULTS

At total of 441 adult patients underwent renal transplantation between January 1, 2010, and December 31, 2011. Of these 441patients, 66 (15%) developed an SSI; of these 66, 31 (47%) were superficial incisional infections and 35 (53%) were deep-incisional or organ-space infections. The average body mass index (BMI) among this patient cohort was 29.7; 84 (42%) were obese (BMI >30). Patients who developed an SSI had a greater mean BMI (31.7 vs 29.4; P=.004) and were more likely to have a history of peripheral vascular disease, rheumatologic disease, and narcotic abuse. History of cerebral vascular disease was protective. Multivariate analysis showed BMI (odds ratio [OR] 1.06; 95% confidence interval [CI], 1.02–1.11) and past history of narcotic use/abuse (OR, 4.86; 95% CI, 1.24–19.12) to be significantly associated with development of SSI after controlling for National Healthcare Surveillance Network (NHSN) score and presence of cerebrovascular, peripheral vascular, and rheumatologic disease.

CONCLUSIONS

We identified higher BMI as a risk factor for the development of SSI following renal transplantation. Notably, neither aggregate comorbidity scores nor NHSN risk index were associated with SSI in this population. Additional risk adjustment measures and research in this area are needed to compare SSIs across transplant centers.

Infect Control Hosp Epidemiol 2015;00(0): 1–7

Type
Original Articles
Information
Infection Control & Hospital Epidemiology , Volume 36 , Issue 4 , April 2015 , pp. 417 - 423
Copyright
© 2015 by The Society for Healthcare Epidemiology of America. All rights reserved 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

REFERENCES

1. Klevens, RM, Edwards, JR, Richards, CL Jr, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep 2007;122:160–166.Google Scholar
2. Anderson, DJ, Kaye, KS, Classen, D, et al. Strategies to prevent surgical site infections in acute care hospitals. Infect Control Hosp Epidemiol 2008;29:S51–S61.Google Scholar
3. Kirkland, KB, Briggs, JP, Trivette, SL, Wilkinson, WE, Sexton, DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol 1999;20:725–730.CrossRefGoogle ScholarPubMed
4. Mangram, AJ, Horan, TC, Pearson, ML, Silver, LC, Jarvis, WR. Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee. Infect Control Hosp Epidemiol 1999;20:250–278; quiz 279–280.CrossRefGoogle ScholarPubMed
5. National Institutes of Health. 2011 Annual Data Report. National Institute of Diabetes and Digestive and Kidney Institute website. http://kidney.niddk.nih.gov/kudiseases/pubs/kustats. Published June 2012. Accessed December 2014.Google Scholar
6. Horan, TC, Andrus, M, Dudeck, MA. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008;36:309–332.CrossRefGoogle ScholarPubMed
7. Schweizer, ML, Furuno, JP, Harris, AD, et al. Comparative effectiveness of nafcillin or cefazolin versus vancomycin in methicillin-susceptible Staphylococcus aureus bacteremia. BMC Infect Dis 2011;11:279.Google Scholar
8. Thom, KA, Johnson, JA, Strauss, SM, Furuno, JP, Perencevich, EN, Harris, AD. Increasing prevalence of gastrointestinal colonization with ceftazidime-resistant Gram-negative bacteria among intensive care unit patients. Infect Control Hosp Epidemiol 2007;28:1240–1246.Google Scholar
9. Deyo, RA, Cherkin, DC, Ciol, MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol 1992;45:613–619.Google Scholar
10. McGregor, JC, Kim, PW, Perencevich, EN, et al. Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms. Am J Epidemiol 2005;161:483–493.Google Scholar
11. Von Korff, M, Wagner, EH, Saunders, K. A chronic disease score from automated pharmacy data. J Clin Epidemiol 1992;45:197–203.Google Scholar
12. McGregor, JC, Perencevich, EN, Furuno, JP, et al. Comorbidity risk-adjustment measures were developed and validated for studies of antibiotic-resistant infections. J Clin Epidemiol 2006;59:1266–1273.Google Scholar
13. Haley, RW, Culver, DH, Morgan, WM, White, JW, Emori, TG, Hooton, TM. Identifying patients at high risk of surgical wound infection. A simple multivariate index of patient susceptibility and wound contamination. Am J Epidemiol 1985;121:206–215.Google Scholar
14. Bratzler, DW, Dellinger, EP, Olsen, KM, et al. Clinical practice guidelines for antimicrobial prophylaxis in surgery. Am J Health-System Pharm 2013;70:195–283.Google Scholar
15. Lynch, RJ, Ranney, DN, Shijie, C, Lee, DS, Samala, N, Englesbe, MJ. Obesity, surgical site infection, and outcome following renal transplantation. Ann Surg 2009;250:1014–1020.Google Scholar
16. Menezes, FG, Wey, SB, Peres, CA, Medina-Pestana, JO, Camargo, LF. Risk factors for surgical site infection in kidney transplant recipients. Infect Control Hosp Epidemiol 2008;29:771–773.Google Scholar
17. Ramos, A, Asensio, A, Munez, E, et al. Incisional surgical site infection in kidney transplantation. Urology 2008;72:119–123.CrossRefGoogle ScholarPubMed
18. Huttunen, R, Syrjanen, J. Obesity and the risk and outcome of infection. Int J Obes (Lond) 2013;37:333–340.Google Scholar
19. Waisbren, E, Rosen, H, Bader, AM, Lipsitz, SR, Rogers, SO Jr, Eriksson, E. Percent body fat and prediction of surgical site infection. J Am Coll Surg 2010;210:381–389.Google Scholar
20. Edwards, JR, Peterson, KD, Mu, Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control 2009;37:783–805.CrossRefGoogle ScholarPubMed
21. Moehring, RW, Anderson, DJ. “But my patients are different!”: risk adjustment in 2012 and beyond. Infect Control Hosp Epidemiol 2011;32:987–989.Google Scholar
22. Sexton, DJ, Chen, LF, Moehring, R, Thacker, PA, Anderson, DJ. Casablanca redux: we are shocked that public reporting of rates of central line-associated bloodstream infections are inaccurate. Infect Control Hosp Epidemiol 2012;33:932–935.CrossRefGoogle ScholarPubMed
23. Harris, AD, McGregor, JC. The importance of case-mix adjustment for infection rates and the need for more research. Infect Control Hosp Epidemiol 2008;29:693–694.Google Scholar
24. Fraser, TG, Gordon, SM. CLABSI rates in immunocompromised patients: a valuable patient centered outcome? Clin Infect Dis 2011;52:1446–1450.CrossRefGoogle ScholarPubMed
25. Mu, Y, Edwards, JR, Horan, TC, Berrios-Torres, SI, Fridkin, SK. Improving risk-adjusted measures of surgical site infection for the national healthcare safety network. Infect Control Hosp Epidemiol 2011;32:970–986.Google Scholar
26. Berrios-Torres, SI, Mu, Y, Edwards, JR, Horan, TC, Fridkin, SK. Improved risk adjustment in public reporting: coronary artery bypass graft surgical site infections. Infect Control Hosp Epidemiol 2012;33:463–469.Google Scholar